Targent Inc. Initiates Phase 2 Oritavancin Infrequent Dosing Study
9/13/2007 7:43:36 AM
More...
|
Targent Inc. Announces Resignation Of CEO
7/6/2006 3:11:35 PM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Completes Acquisition Of Oncology Drug Assets Of Targent Inc.
4/24/2006 11:11:40 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) To Acquire NDA For An Oncology Drug And Other Assets
3/20/2006 10:29:22 AM
More...
|
Targent Inc. Reports Transfer Of Orphan Drug Designations Relating To Isovorin -L-Leucovorin- For Colon Cancer Indication And For Osteosarcoma
10/19/2005 5:12:54 PM
More...
|
Targent Inc. Announces The In-licensing Of Oncology Drug For Colorectal Cancer
10/19/2005 5:10:16 PM
More...
|
Targent Inc. Announces Acquisition Of Oncology Drug For Brain Cancer
10/19/2005 5:09:30 PM
More...
|